NCT06127667

Brief Summary

This is a single-arm, two-visit, non-randomized, cross sectional study identified as an intervention due to the use of a single bout of aerobic exercise to assess cerebrovascular function under the NIH rules. This study is not masked and its primary purpose is to develop a basic science understanding of the relationship between cerebrovascular health and balance control with aging. This study will involve 102 individuals classified as younger adults, middle-aged adults, and older adults who are neurotypical and cognitively normal. The primary outcome from a clinical trials perspective will be cerebrovascular response to a bout of aerobic exercise (i.e. change in cerebral blood flow with the performance of aerobic exercise on a recumbent stepper exercise machine). Non-interventional outcomes will be EEG measures of cortical activity and biomechanical kinetic and kinematic data recorded during standing balance reactions, as well as biological blood samples for genomic analysis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
26mo left

Started Oct 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Oct 2024Jul 2028

First Submitted

Initial submission to the registry

October 29, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
11 months until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

3.7 years

First QC Date

October 29, 2023

Last Update Submit

March 26, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • cerebral blood flow velocity assessed using transcranial Doppler ultrasound

    Includes recordings from transcranial Doppler ultrasound of cerebral blood flow (CBF) velocity performed at the first session during rest, sit-to-stand, transfer, and single bout of aerobic exercise.

    1 week

  • Kinetic center of pressure rate of rise post-balance perturbation, assessed biomechanically.

    Recordings from 64-channels of EEG electrodes, kinetic, and kinematic biomechanical data during standing balance reactions will be collected.

    1 week

  • Prefrontal-M1 coherence an S1-M1 coherence post-balance perturbation, assessed using EEG

    Recordings from 64-channels of EEG electrodes, kinetic, and kinematic biomechanical data during standing balance reactions will be collected.

    1 week

Study Arms (1)

Experimental group

EXPERIMENTAL

Healthy participants in 3 age groups

Behavioral: aerobic exercise

Interventions

use of single bout of aerobic exercise

Experimental group

Eligibility Criteria

Age21 Years - 95 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age within the following 3 group age ranges, 21-30yo; middle-aged: 40-55yo; older: 65-95yo adults
  • the absence of major orthopedic disability
  • cognitively normal (MoCA score ≥ 26/30 in older adult group)
  • vision that is 20/40 or better with or without corrective lenses, (5) the ability to consent and communicate with researchers
  • English speaking
  • ability to stand for 3 minutes and walk 10 meters with or without an assistive device and without the assistance of another person.

You may not qualify if:

  • insulin-dependent diabetes
  • peripheral neuropathy
  • myocardial infarction or symptoms of coronary artery disease within 2 years
  • congestive heart failure or class IV heart failure
  • any significant sensory impairment affecting balance or cognition; visual, vestibular, or auditory impairments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55414, United States

RECRUITING

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jacqueline Palmer

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jacqueline Palmer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2023

First Posted

November 13, 2023

Study Start

October 15, 2024

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

March 27, 2026

Record last verified: 2026-03

Locations